Reversal by the specific antidote, idarucizumab, of elevated dabigatran exposure in a patient with rectal perforation and paralytic ileus

Thorborg, C., Horn, E. P., Mofid, H., & Langer, F. (2016, September 1). Reversal by the specific antidote, idarucizumab, of elevated dabigatran exposure in a patient with rectal perforation and paralytic ileus. British Journal of Anaesthesia. Oxford University Press. https://doi.org/10.1093/bja/aew244